Dexmedetomidine for infant pulmonary function testing
- 3 September 2014
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 50 (2) , 150-154
Abstract
For the last thirty years, oral chloral hydrate has been used for sedation of infants for lung function testing. Recently, however, availability of chloral hydrate became severely limited in the United States after two manufacturers discontinued manufacturing in 2012. Due to these limitations and the recent and ongoing shortage of chloral hydrate, other medications have been proposed for lung function testing, including midazolam and propofol. Herein, we describe our limited experience using intravenous dexmedetomedine (DMED), a medication thus far described as having minimal effect on pulmonary function or respiratory drive. Pediatr Pulmonol. 2015; 50:150–154.Keywords
This publication has 22 references indexed in Scilit:
- Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancyPediatric Pulmonology, 2012
- Comparison of buccal and nasal dexmedetomidine premedication for pediatric patientsPediatric Anesthesia, 2012
- Potential misinterpretation of infant lung function unless prospective healthy controls are studiedPediatric Pulmonology, 2010
- Anaesthesia or sedation for MRI in childrenCurrent Opinion in Anaesthesiology, 2010
- The Impact of Oral Premedication with Midazolam on Respiratory Function in ChildrenAnesthesia & Analgesia, 2009
- High dose dexmedetomidine as the sole sedative for pediatric MRIPediatric Anesthesia, 2008
- Decrease of Functional Residual Capacity and Ventilation Homogeneity after Neuromuscular Blockade in Anesthetized Young Infants and Preschool ChildrenAnesthesiology, 2006
- Dexmedetomidine Pharmacodynamics: Part IAnesthesiology, 2004
- Forced Expiratory Flows and Volumes in Infants: Normative Data and Lung GrowthAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Multicentre study of propofol in day case surgeryAnaesthesia, 1988